Literature DB >> 32214346

Glomerular endothelial derived vesicles mediate podocyte dysfunction: A potential role for miRNA.

N Hill1, D L Michell2, M Ramirez-Solano3, Q Sheng3, C Pusey1, K C Vickers2, K J Woollard1.   

Abstract

MicroRNAs (miRNA) are shown to be involved in the progression of several types of kidney diseases. Podocytes maintain the integrity of the glomerular basement membrane. Extracellular vesicles (EV) are important in cell-to-cell communication as they can transfer cellular content between cells, including miRNA. However, little is known about how extracellular signals from the glomerular microenvironment regulate podocyte activity. Using a non-contact transwell system, communication between glomerular endothelial cells (GEnC) and podocytes was characterised in-vitro. Identification of transferred EV-miRNAs from GEnC to podocytes was performed using fluorescence cell tracking and miRNA mimetics. To represent kidney disease, podocyte molecular profiling and functions were analysed after EV treatments derived from steady state or activated GEnC. Our data shows activation of GEnC alters EV-miRNA loading, but activation was not found to alter EV secretion. EV delivery of miRNA to recipient podocytes altered cellular miRNA abundance and effector functions in podocytes, including decreased secretion of VEGF and increased mitochondrial stress which lead to altered cellular metabolism and cytoskeletal rearrangement. Finally, results support our hypothesis that miRNA-200c-3p is transfered by EVs from GEnC to podocytes in response to activation, ultimately leading to podocyte dysfunction.

Entities:  

Year:  2020        PMID: 32214346     DOI: 10.1371/journal.pone.0224852

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  7 in total

Review 1.  Bioengineering Strategies to Develop Podocyte Culture Systems.

Authors:  Sarah Williams; Joseph L Charest; Martin R Pollak; Balajikarthick Subramanian
Journal:  Tissue Eng Part B Rev       Date:  2021-12-08       Impact factor: 7.376

2.  An engineered CD81-based combinatorial library for selecting recombinant binders to cell surface proteins: Laminin binding CD81 enhances cellular uptake of extracellular vesicles.

Authors:  Stefan Vogt; Madhusudhan Reddy Bobbili; Gerhard Stadlmayr; Katharina Stadlbauer; Jørgen Kjems; Florian Rüker; Johannes Grillari; Gordana Wozniak-Knopp
Journal:  J Extracell Vesicles       Date:  2021-09

Review 3.  Extracellular vesicles in kidney disease.

Authors:  Cristina Grange; Benedetta Bussolati
Journal:  Nat Rev Nephrol       Date:  2022-05-31       Impact factor: 42.439

Review 4.  To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Maurice B Fluitt; Neal Mohit; Kanwal K Gambhir; Gail Nunlee-Bland
Journal:  J Diabetes Res       Date:  2022-02-21       Impact factor: 4.011

Review 5.  Glomerular cell cross talk in diabetic kidney diseases.

Authors:  Ruixue Dong; Youhua Xu
Journal:  J Diabetes       Date:  2022-08-23       Impact factor: 4.530

6.  A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype.

Authors:  Hafeez S Haniff; Xiaohui Liu; Yuquan Tong; Samantha M Meyer; Laurent Knerr; Malin Lemurell; Daniel Abegg; Haruo Aikawa; Alexander Adibekian; Matthew D Disney
Journal:  Cell Chem Biol       Date:  2021-07-27       Impact factor: 8.116

Review 7.  In sickness and in health: The functional role of extracellular vesicles in physiology and pathology in vivo: Part I: Health and Normal Physiology: Part I: Health and Normal Physiology.

Authors:  Abi G Yates; Ryan C Pink; Uta Erdbrügger; Pia R-M Siljander; Elizabeth R Dellar; Paschalia Pantazi; Naveed Akbar; William R Cooke; Manu Vatish; Emmanuel Dias-Neto; Daniel C Anthony; Yvonne Couch
Journal:  J Extracell Vesicles       Date:  2022-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.